Ibuprofen and Famotidine
- Product NDC
- 72578-214
- Requested package NDC
- 72578-214-16
- 11-digit product format
- 725780214
- Labeler code
- 72578
- Product ID
- 72578-214_d0498b4c-d60a-4a93-b151-d3bc4658787a
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Ibuprofen and Famotidine
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Viona Pharmaceuticals Inc
- Application
- ANDA218684
- Marketing category
- ANDA
- Marketing start
- 2025-06-01
- Substance
- IBUPROFEN; FAMOTIDINE
- Active strength
- 800; 26.6 mg/1; mg/1
- Pharmacologic classes
- Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A218684-001 | IBUPROFEN AND FAMOTIDINE | FAMOTIDINE; IBUPROFEN | 26.6MG;800MG | TABLET / ORAL | AB | 2025-02-20 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A218684-001 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A218684-001 | IBUPROFEN AND FAMOTIDINE | 26.6MG;800MG | TABLET / ORAL | AB | 2025-02-20 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A218684-001 | IBUPROFEN AND FAMOTIDINE | 26.6MG;800MG | TABLET / ORAL | AB | 2025-02-20 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A218684-001 | IBUPROFEN AND FAMOTIDINE | 26.6MG;800MG | TABLET / ORAL | AB | 2025-02-20 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A218684-001 | IBUPROFEN AND FAMOTIDINE | 26.6MG;800MG | TABLET / ORAL | AB | 2025-02-20 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A218684-001 | IBUPROFEN AND FAMOTIDINE | 26.6MG;800MG | TABLET / ORAL | AB | 2025-02-20 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A218684-001 | IBUPROFEN AND FAMOTIDINE | 26.6MG;800MG | TABLET / ORAL | AB | 2025-02-20 | fd3edfee7708… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A218684-001 | IBUPROFEN AND FAMOTIDINE | 26.6MG;800MG | TABLET / ORAL | AB | 2025-02-20 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A218684-001 | AB | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A218684-001 | AB | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A218684-001 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A218684-001 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A218684-001 | AB | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A218684-001 | AB | 1 | fd3edfee7708… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A218684-001 | AB | 1 | a50c72e98297… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Ibuprofen and Famotidine
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| IBUPROFEN | 800 mg/1 |
| FAMOTIDINE | 26.6 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| WK2XYI10QM | Internal UNII lookup |
| 5QZO15J2Z8 | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 1100066 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 66524c84-35bc-4e7f-897a-f63fa4bca432 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 396bde5c-c78e-2f8b-ab1f-2ee6ba32bcae | Product name | 7 | 20260317 |
| 1e73f975-1ce7-705e-2bcf-788b1b5e24ba | Product name | 5 | 20251124 |
| cf645750-2e70-f6e1-c05a-a52847def5dd | Product name | 9 | 20250312 |
| 16cde546-8deb-4df2-a072-dab5566ede95 | Product name | 1 | 20231003 |
| f6d1b8d7-3bd1-4248-eddd-b60565c88015 | Product name | 4 | 20230808 |
| 874f4e63-49d2-5150-5d77-052172814ebd | Product name | 6 | 20230105 |
| 4fdc761c-585e-054b-8ebe-86130a26e4c1 | Product name | 2 | 20221205 |
| 557673c2-8256-b351-e863-4ec71a5a64b0 | Product name | 2 | 20160714 |
| dbc9a339-6215-4e94-9546-57a3b34902ce | Product name | 1 | 20160517 |
| 61c18d4e-b552-5478-8fc0-df38b93e3100 | Product name | 1 | 20140508 |
| 7b2938c9-7eb7-e312-ae90-f54f4240361e | Product name | 1 | 20140508 |
| 997601aa-bb5f-6971-6b90-a21132c12c7b | Product name | 1 | 20140508 |
| fc2e1e31-353a-2c24-a4b4-fcf93bf7e38e | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 72578-214-16 | Ibuprofen and Famotidine | 90 in 1 BOTTLE | TABLET | 90 | 1 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 72578-214-16 | EA - Each | 72578-214 | 73d594bb-6c0a-4eeb-bcf2-e790894a189e | 1 | 2026-03-17 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ibuprofen Famotidine | IBUPROFEN FAMOTIDINE | Direct_Rx | 54d9e1fc-507d-1859-e063-6394a90a8c6b | 2026-06-22 | Boxed warning, Warnings, Adverse reactions | 218684 ANDA218684 |
| Ibuprofen and Famotidine | IBUPROFEN AND FAMOTIDINE | Advanced Rx of Tennessee, LLC | 548c705e-4094-fc6f-e063-6394a90a3426 | 2026-06-18 | Boxed warning, Warnings, Adverse reactions | 218684 ANDA218684 |
| Ibuprofen and Famotidine | IBUPROFEN AND FAMOTIDINE | Zydus Lifesciences Limited | 24204938-0989-42ad-8ad8-89979e62d700 | 2025-05-28 | 218684 ANDA218684 | |
| Ibuprofen and Famotidine | IBUPROFEN AND FAMOTIDINE | Viona Pharmaceuticals Inc | 66524c84-35bc-4e7f-897a-f63fa4bca432 | 2025-05-28 | Boxed warning, Warnings, Adverse reactions | 218684 ANDA218684 72578-214-16 72578-214 72578021416 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 1100066 | ibuprofen 800 MG / famotidine 26.6 MG Oral Tablet | PSN | 66524c84-35bc-4e7f-897a-f63fa4bca432 | 1 |
| 1100066 | famotidine 26.6 MG / ibuprofen 800 MG Oral Tablet | SCD | 66524c84-35bc-4e7f-897a-f63fa4bca432 | 1 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 72578-214-16 | 72578021416 | 90 TABLET in 1 BOTTLE (72578-214-16) | 90 tablet | 2025-06-01 | No | No | Current |